Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1997-09-29
1999-04-20
Jordan, Kimberly
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514220, 514468, 514548, A61K 3155, A61K 3134, A61K 31225
Patent
active
058957855
ABSTRACT:
The invention refers to the composition of substances to prevent and treat endothelial cell-mediated disorders with pathological differentiation of endothelial cells, for example, in response to insulin, lipids, lipoproteins or LA-paf. The invention refers to simple methods to test and use antagonists against LA-paf, paf and very high affinity receptors on endothelial cells which can also be cultured on soluble particles for screening procedures. According to the invention genes producing very high affinity receptors, for example, in response to growth factors such as insulin. These genes can be transferred from adherent endothelial cell lines to soluble cells using standard procedures. Antagonists against LA-paf, paf and very high affinity receptors are administered by preference to healthy persons having risk factors to protect against aging and metabolic, genetic, chronicle, idiopathic, inflammatory or degenerative disorders. The antagonists can be administered by preference with food or topically, for example, with beauty products.
REFERENCES:
patent: 4183912 (1980-01-01), Rosenthale
patent: 4571407 (1986-02-01), Chatterjee et al.
patent: 4582824 (1986-04-01), Nishikawa et al.
patent: 4595693 (1986-06-01), Biftu et al.
patent: 4621083 (1986-11-01), Casals-Stenzel et al.
patent: 4734280 (1988-03-01), Braquet
patent: 4900729 (1990-02-01), Stransky et al.
patent: 5147864 (1992-09-01), Wissner et al.
patent: 5202313 (1993-04-01), Bombardelli et al.
patent: 5334592 (1994-08-01), Billah
patent: 5346894 (1994-09-01), Korth
patent: 5356791 (1994-10-01), Korth
patent: 5399348 (1995-03-01), Schwabe
Jordan Kimberly
Korth Ruth
LandOfFree
Treatment and prevention of disorders mediated by LA-paf or endo does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment and prevention of disorders mediated by LA-paf or endo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment and prevention of disorders mediated by LA-paf or endo will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2247974